ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Infectious Disease

Top Infectious Disease Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SARAH D'HEILLY M.D.

Infectious Disease

11,555

$777K

403
168 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 41%

$67
Average prescription price

Avg: $340

RONALD SCHUT MD

Infectious Disease

6,065

$2.84M

142
13 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 41%

$469
Average prescription price

Avg: $340

WILLIAM HENRY MD

Infectious Disease

5,298

$2.17M

129
18 are 65+

26%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 41%

$410
Average prescription price

Avg: $340

FRANK RHAME MD

Infectious Disease

4,554

$2.32M

134
20 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 41%

$510
Average prescription price

Avg: $340

MARK SANNES

Infectious Disease

3,154

$1.18M

520
412 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 41%

$373
Average prescription price

Avg: $340

LESLIE BAKEN MD

Infectious Disease

2,533

$1.1M

189
112 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 41%

$435
Average prescription price

Avg: $340

MARGARET SIMPSON MD

Infectious Disease

2,257

$776K

37
0 are 65+

32%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 41%

$344
Average prescription price

Avg: $340

KAY SCHWEBKE MD

Infectious Disease

1,526

$752K

29
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 41%

$493
Average prescription price

Avg: $340

CHRISTIAN SCHROCK MD

Infectious Disease

1,372

$192K

213
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 41%

$140
Average prescription price

Avg: $340

ELLIOT FRANCKE M.D.

Infectious Disease

1,353

$355K

132
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 41%

$262
Average prescription price

Avg: $340

THIHA TIN MD

Infectious Disease

1,301

$329K

106
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 41%

$253
Average prescription price

Avg: $340

THOMAS MATH MD

Infectious Disease

1,169

$376K

180
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 41%

$322
Average prescription price

Avg: $340

STEVEN DITTES M.D.

Infectious Disease

1,085

$397K

108
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 41%

$366
Average prescription price

Avg: $340

NILA SUNTHARAM

Infectious Disease

1,018

$364K

139
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 41%

$357
Average prescription price

Avg: $340

MARY ANN KISH MD

Infectious Disease

1,011

$523K

52
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 41%

$517
Average prescription price

Avg: $340

ALISON BORMANN M.D

Infectious Disease

969

$442K

57
0 are 65+

33%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 41%

$456
Average prescription price

Avg: $340

WINSTON CAVERT MD

Infectious Disease

843

$652K

41
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 41%

$773
Average prescription price

Avg: $340

JANET LARSON M.D.

Infectious Disease

803

$376K

160
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 41%

$469
Average prescription price

Avg: $340

ALBERTO RICART M.D.

Infectious Disease

798

$94.4K

145
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 41%

$118
Average prescription price

Avg: $340

CRISTINA BAKER MD

Infectious Disease

761

$219K

147
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 41%

$288
Average prescription price

Avg: $340

DANIEL ZYDOWICZ MD

Infectious Disease

750

$295K

82
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 41%

$394
Average prescription price

Avg: $340

JO ANNE YOUNG MD

Infectious Disease

626

$215K

86
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 41%

$344
Average prescription price

Avg: $340

JASON SANCHEZ M.D.

Infectious Disease

620

$142K

148
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 41%

$229
Average prescription price

Avg: $340

SHEWANGIZAW WORKU M.D., PHD

Infectious Disease

597

$206K

85
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 41%

$344
Average prescription price

Avg: $340

NICHOLAS VOGENTHALER M.D.

Infectious Disease

595

$305K

66
0 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 41%

$512
Average prescription price

Avg: $340

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank